Microbiome sequencing services include identification of microbial communities present in the human body through Next Generation Sequencing (NGS) techniques. Microbiome sequencing plays a vital role in understanding human health and various diseases by analyzing the bacterial composition in different parts of the human body such as gut, skin, nose, mouth, and others. The growing adoption of microbiome therapeutics and growing demand for personalized medicine are major factors driving the growth of the microbiome sequencing service market.

The Global Microbiome Sequencing Service Market is estimated to be valued at US$ 4.13 Bn in 2024 and is expected to exhibit a CAGR of 11.% over the forecast period from 2024 to 2031.

Key Takeaways

Key players operating in the Microbiome Sequencing Service are Microbiome Insights Inc., Baseclear B.V., Clinical Microbiomics A/S, Mérieux NutriSciences Corporation, MR DNA, Zymo Research Corporation, Metabiomics Corp., uBiome, Inc., Microbiome Therapeutics Innovation Group, Locus Biosciences, Inc., OpenBiome, Shanghai Ruiyi Biotechnology Co., Ltd., Resphera Biosciences, LLC, Molzym GmbH & Co. KG, BioSpherex LLC, and Diversigen. These players arefocusing on increasing their Microbiome Sequencing Service Market Demand offeringsto cater to the growing demand for identification and management of various chronic diseases.

The growing demand for personalized medicine is one of the major factors driving the growth of the global microbiome sequencing service market. Personalized medicine helps in designing medical treatment, therapies, and prevention strategies considering an individual's variability in genes, environment, and lifestyle. Microbiome sequencing plays a vital role in developing personalized therapeutic strategies for various diseases.

Get More Insights On- Microbiome Sequencing Service Market

Explore More Related Topic On- Alcohol Ethoxylates Market